Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(44%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
7
78%
Ph phase_3
1
11%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(4)
Completed(2)
Other(3)

Detailed Status

Recruiting2
Active, not recruiting2
Completed2
unknown2
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (12.5%)
N/A7 (87.5%)

Trials by Status

recruiting222%
active_not_recruiting222%
completed222%
suspended111%
unknown222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9